
IndraLab
Statements
sparser
"Interestingly, one d-sotalol (0) or l-sotalol(+) molecule was observed to bind deep into the hERG pore, just below the SF region and interact with the canonical drug binding F656 and Y652 hERG residues [ xref – xref ] in the pore lining S6 helices (drug molecule M2 in xref and xref ) for most of 8 μs long MD runs, while another drug molecule was observed to transiently bind below, interacting with F656 and/or Y652 from another domain as well as S660 and other residues at the bottom of S6 helices (M1 in xref and xref )."
sparser
"Interestingly, for l-sotalol(0) and d-sotalol(+) systems, we observed only transient binding of one or two drug molecules at the bottom of hERG channel pore interacting with S660 and other S6 helix residues there ( xref and xref and xref and xref ) Hence up to two sotalol molecules were able to bind to the hERG pore, in agreement with our electrophysiological data (as described below)."
sparser
"The direct block was mediated by drug binding to S6 domain of the hERG subunit, while trafficking deficiency was mediated by binding to a different site or a related protein. xref In this study, we used site-directed mutagenesis to test whether Y652A or F656V mutation alter the BBR sensitivity of hERG after long-term treatment."